Dr. Joseph A. Readling
Education
Summa cum Laude in Chemistry
5/73 – 5/77 A.B. Hamilton College
Clinton, NY
Doctor of Medicine
9/77 – 5/81 University of Rochester School Of Medicine and Dentistry
Rochester, New York
Licensure & Professional
Diplomate, National Board of Medical Examiners Certificate #242228
New York State License #153623-1
Pennsylvania State License #040415-E
NPI # 1275522831
UPIN #E57879
Training
Intern, Internal Medicine
7/81 – 6/82 University Of Minnesota Hospitals
Minneapolis, MN
Assistant and Associate Resident, Internal Medicine
7/82 – 6/84 Strong Memorial Hospital
Instructor and Fellow in Medicine (Medical Oncology)
7/84 – 6/86 University of Rochester
Rochester, NY
Instructor and Fellow in Medicine (Hematology)
7/86 – 12/86 University of Rochester
Rochester, NY
Affiliation
Member, American Society of Clinical Oncology
Work Experience
Associate Director, Medical Oncology
Our Lady of Lourdes Memorial Hospital
Binghamton, NY
12/86 – 9/89
Director, Medical Oncology
Our Lady of Lourdes Memorial Hospital
Binghamton, NY
9/89 – 12/93
Director, Oncology Program
Our Lady of Lourdes Memorial Hospital
Binghamton, NY
12/93 – 12/01
Founder, Managing Partner and Medical Oncologist
Broome Oncology LLC
Johnson City, NY
12/01 – 12/06
President, Broome Trading, LLC
1/07-12/08
Part-time independent contractor Oncologist, Wayne Memorial
Hospital,
Honesdale, PA
2/09-11/09
Staff Oncologist, Broome Oncology, LLC
2/09-Present
Publications
Phase 2 Trial of Trimetrexate for Non-resectable or Metastatic Non-Small Cell Bronchogenic Carcinoma, Investigational New Drugs 10(4): 331-5 (1992)
Fossella FV, Winn RJ, Holoye PY, Hallinan B, Raber MN, Young JA, Readling J, Bowers B, and Hong WK,
PTransformation of Follicular Lymphoma to Burkitt-Like Lymphoma Within a Single Lymph Node, Human Pathology 36(5): 571-5 (2005)
Mukhopadhysy S, Readling J, Cotter PD, Shrimpton AE, and Sidhu JS,
Board Certification
American Board of Internal Medicine
Internal Medicine —1984
Medical Oncology —1987